These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39073345)

  • 1. Formation of EGFRwt/EGFRvIII homo- and hetero-dimers in glioblastoma cells as detected by single molecule localization microscopy.
    Jahnke K; Struve N; Hofmann D; Gote MJ; Bach M; Kriegs M; Hausmann M
    Nanoscale; 2024 Aug; 16(32):15240-15255. PubMed ID: 39073345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustered localization of EGFRvIII in glioblastoma cells as detected by high precision localization microscopy.
    Boyd PS; Struve N; Bach M; Eberle JP; Gote M; Schock F; Cremer C; Kriegs M; Hausmann M
    Nanoscale; 2016 Dec; 8(48):20037-20047. PubMed ID: 27883139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII.
    Li L; Chakraborty S; Yang CR; Hatanpaa KJ; Cipher DJ; Puliyappadamba VT; Rehman A; Jiwani AJ; Mickey B; Madden C; Raisanen J; Burma S; Saha D; Wang Z; Pingle SC; Kesari S; Boothman DA; Habib AA
    Oncogene; 2014 Aug; 33(33):4253-64. PubMed ID: 24077285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ analysis of mutant EGFRs prevalent in glioblastoma multiforme reveals aberrant dimerization, activation, and differential response to anti-EGFR targeted therapy.
    Gajadhar AS; Bogdanovic E; Muñoz DM; Guha A
    Mol Cancer Res; 2012 Mar; 10(3):428-40. PubMed ID: 22232519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).
    Chu CT; Everiss KD; Wikstrand CJ; Batra SK; Kung HJ; Bigner DD
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):855-61. PubMed ID: 9210410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effect of EGFRWT on EGFRvIII-mediated NF-κB activation with RIP1 as a cell death switch.
    Puliyappadamba VT; Chakraborty S; Chauncey SS; Li L; Hatanpaa KJ; Mickey B; Noorani S; Shu HK; Burma S; Boothman DA; Habib AA
    Cell Rep; 2013 Aug; 4(4):764-75. PubMed ID: 23972990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation.
    Kancha RK; von Bubnoff N; Duyster J
    Cell Commun Signal; 2013 Jun; 11():39. PubMed ID: 23758840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
    Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
    Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
    Li L; Puliyappadamba VT; Chakraborty S; Rehman A; Vemireddy V; Saha D; Souza RF; Hatanpaa KJ; Koduru P; Burma S; Boothman DA; Habib AA
    Oncogene; 2015 Jan; 34(1):129-134. PubMed ID: 24362532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy.
    Chandramohan V; Bao X; Keir ST; Pegram CN; Szafranski SE; Piao H; Wikstrand CJ; McLendon RE; Kuan CT; Pastan IH; Bigner DD
    Clin Cancer Res; 2013 Sep; 19(17):4717-27. PubMed ID: 23857604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F25P preproinsulin abrogates the secretion of pro-growth factors from EGFRvIII cells and suppresses tumor growth in an EGFRvIII/wt heterogenic model.
    Wei JW; Cui JQ; Zhou X; Fang C; Tan YL; Chen LY; Yang C; Liu M; Kang CS
    Cancer Lett; 2016 Sep; 380(1):1-9. PubMed ID: 27317648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.
    Gilder AS; Jones KA; Hu J; Wang L; Chen CC; Carter BS; Gonias SL
    J Biol Chem; 2015 Jun; 290(24):14798-809. PubMed ID: 25837250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
    Hu J; Jo M; Cavenee WK; Furnari F; VandenBerg SR; Gonias SL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15984-9. PubMed ID: 21896743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.
    Keir ST; Chandramohan V; Hemphill CD; Grandal MM; Melander MC; Pedersen MW; Horak ID; Kragh M; Desjardins A; Friedman HS; Bigner DD
    J Neurooncol; 2018 Jul; 138(3):489-498. PubMed ID: 29564747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
    Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
    Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK-mediated negative feedback regulation of oncogenic EGFRvIII in glioblastoma cells.
    Haryuni RD; Tanaka T; Zhou Y; Yokoyama S; Sakurai H
    Oncol Lett; 2020 Sep; 20(3):2477-2482. PubMed ID: 32782566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment.
    Guo G; Narayan RN; Horton L; Patel TR; Habib AA
    Curr Cancer Drug Targets; 2017; 17(3):297-302. PubMed ID: 28004613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression.
    Martinez-Jaramillo E; Jamali F; Abdalbari FH; Abdulkarim B; Jean-Claude BJ; Telleria CM; Sabri S
    Cancers (Basel); 2024 Jun; 16(13):. PubMed ID: 39001381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.
    Stockhausen MT; Kristoffersen K; Stobbe L; Poulsen HS
    Cancer Biol Ther; 2014 Feb; 15(2):216-24. PubMed ID: 24525857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.